Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care

Clin Chim Acta. 2022 Nov 1:536:104-111. doi: 10.1016/j.cca.2022.09.014. Epub 2022 Sep 17.

Abstract

Over the past two years, SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus 2) infection has spread globally causing multi-organ disease and severely impacting the healthcare systems of all countries. Accordingly, the development of easy-to-access diagnostic devices has become essential to limit the effect of the virus worldwide. Real-Time PCR is considered the gold standard to identify SARS-CoV-2 infection due to high sensitivity, affordability, and capacity to detect low viral loads at early disease stage. Advances in lab on a chip technology has led to the development of some Point-of-Care (POC) devices using Real-Time PCR and approved by the United States Food and Drug Administration. We provide an overview on recently developed POC tests for the rapid diagnosis of COVID-19 infection. Practical applications of miniaturized devices based on viral genome amplification as well as favorable features such as reduced sample processing time, ease of use by non-specialized personnel, and the potential of PCR-based POC technologies will be highlighted and reviewed.

Keywords: Lab On Chip; Molecular Biology; Point of Care; Real-Time PCR; SARS-CoV-2; Viral infection.

Publication types

  • Review

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Humans
  • Point-of-Care Systems
  • Point-of-Care Testing
  • Real-Time Polymerase Chain Reaction
  • SARS-CoV-2* / genetics
  • Sensitivity and Specificity